Evidence map›Paper›PMID 41019477›Full record

ArticleExperimental and therapeutic medicine2025

Demographics, cardiopulmonary comorbidities, laboratory data and length of hospital stay in patients with acute exacerbation of chronic obstructive pulmonary disease at high altitude: A comparative study.

Yuying Tan, Bi Ran, Fangying Chen, Lin Liu, Lei Chen

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuying TanDepartment of High Altitude Medicine, Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Bi RanDepartment of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Fangying ChenDepartment of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Lin LiuDepartment of Pulmonary and Critical Care Medicine, 363 Hospital, Chengdu, Sichuan 610041, P.R. China.
Lei ChenDepartment of High Altitude Medicine, Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is known to impose a significant burden on patients, but its demographic and clinical features in patients with AECOPD at high altitude (HA) still need to be addressed. A total of 142 patients with AECOPD at HA [>2,500 meters (m)] and 142 patients with AECOPD at low altitude (LA) (<500 m) as controls, matched 1:1 by age and sex, encountered at West China Hospital of Sichuan University (Chengdu, China) between January 2023 and December 2023, were retrospectively analyzed. Demographics, cardiopulmonary comorbidities, laboratory data and length of hospital stay (LOHS) of patients with AECOPD at HA and LA were comparatively analyzed. Univariate and multivariate binary logistic regression analyses were used to identify factors associated with prolonged LOHS in patients with AECOPD at HA. Compared to the LA group, patients with AECOPD at HA, regardless of sex and age, demonstrate certain different demographic and clinical features, including more Tibetans and non-smokers, different prevalences of cardiopulmonary comorbidities and indicators in blood routine and biochemical tests, particularly higher hemoglobin levels and eosinophils count, which were negatively associated with LOHS. The present findings highlight that these differences could play an important role in the evaluation and prognosis of AECOPD at HA, and future studies should investigate the mechanisms underlying these differences and explore novel interventions to improve clinical outcomes for patients with AECOPD at HA.

Indexed as

acute exacerbationchronic obstructive pulmonary diseaseeosinophilhigh altituderisk factors

Identifiers

PMID41019477
PMCPMC12464659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.